• 2',7'-Dichlorofluorescein diacetate ROS Workflow

  2026-08-14

  Turn a broadly responsive redox dye into a controlled intracellular ROS measurement workflow for microscopy, flow cytometry, and plate assays. The approach translates findings from a ROS-responsive pancreatic cancer nanocarrier study into practical controls, assay conditions, and interpretation safeguards.

• DM-β-CD Raises Mianserin HCl Cytotoxicity

  2026-08-14

  The reference study shows that heptakis (2,6-di-O-methyl)-β-cyclodextrin forms an inclusion complex with mianserin hydrochloride but does not reduce its cellular toxicity. Instead, the methylated cyclodextrin increased toxicity in B14 cell assays, emphasizing that improved drug solubility or complex formation does not necessarily produce a safer formulation.

• AMPK–p62 Feedback Under Metabolic Stress

  2026-08-13

  This 2024 study identifies a double-positive feedback loop in which metabolic stress activates both AMPK and SQSTM1/p62, coordinating NRF2-dependent antioxidant defense with energy adaptation. The findings connect lysosomal acidification, TFEB/TFE3 regulation, ROS-dependent TAK1 signaling, and KEAP1 degradation, offering a mechanistic explanation for pathway cooperation in metabolically stressed lung cancer cells.

• PRMT5, Splicing, and Metabolism in MYCN Neuroblastoma

  2026-08-13

  This Cancer Letters study defines a mechanistic connection between PRMT5-dependent splicing, epitranscriptomic regulation, and glutamine metabolism in MYCN-amplified neuroblastoma. Its integrated pharmacological, transcriptomic, isotope-tracing, molecular, and mouse-model evidence identifies altered glutaminase regulation as a major component of spliceosomal vulnerability and provides a framework for testing downstream metabolic dependencies.

• Pollen Interference in EEM Hazard Detection

  2026-08-12

  A 2024 Molecules study shows that pollen can distort fluorescence-based classification of hazardous bioaerosols, but spectral transformations—especially fast Fourier transform processing—can substantially improve recognition. The work combines excitation–emission matrix spectroscopy with preprocessing and random forest classification to distinguish pollen from bacterial and toxin-related signals.

• Novel PDK4 Inhibitors for Metabolic Disease

  2026-08-12

  This 2019 Journal of Medicinal Chemistry study describes an anthraquinone-derived series of allosteric pyruvate dehydrogenase kinase 4 inhibitors, identifying compound 8c as a potent biochemical hit with activity in metabolic, allergic, and cancer-related models. Its combination of structure–activity optimization, metabolic and pharmacokinetic profiling, docking, and mouse efficacy studies provides a useful preclinical framework for developing PDK4-directed therapies.

• Hexamethonium Bromide in Autonomic Assays

  2026-08-11

  Learn how Hexamethonium Bromide, SKU B1592, can serve as a mechanistic probe when cholinergic signaling may confound cell viability, proliferation, or cardiovascular experiments. This scenario-based guide covers assay interpretation, protocol planning, solution handling, and evidence-based product selection.

• PTT and CD47 Blockade in Oral Cancer

  2026-08-11

  A 2026 study shows that photothermal therapy (PTT) can overcome two major barriers to CD47-based macrophage therapy in oral squamous cell carcinoma: insufficient pro-phagocytic signaling and poor macrophage access to tumor cells. By inducing calreticulin exposure and remodeling the extracellular matrix, PTT substantially improves the antitumor activity of CD47 blockade in vitro and in vivo.

• CCK-8 in Lipotoxicity: Measuring Mechanism, Not Just Cells

  2026-08-10

  A mechanistic guide to using Cell Counting Kit-8 in palmitate–albumin lipotoxicity studies, with practical controls for distinguishing true cell injury from formulation and metabolic artifacts.

• Bafilomycin A1: From pH Biology to Translation

  2026-08-09

  A translational framework for using Bafilomycin A1 as a reversible V-ATPase inhibitor to distinguish lysosomal acidification, autophagy flux, and oxidative-stress responses, extending findings from sinapine-treated C2C12 myoblasts into broader cell biology, cancer research, and bone-resorption workflows.

• 5X Protein Loading Buffer (Reducing): SDS-PAGE Guide

  2026-08-08

  5X Protein Loading Buffer (Reducing) supports denaturing, reducing protein sample preparation before SDS-PAGE electrophoresis by combining SDS, a sulfhydryl reducing agent, tracking dye, and buffer salts. It is intended for molecular weight-based protein separation and should not be used when native protein structure or non-reducing conditions must be preserved.

• Caspase-3, NDUFS1, and Trichothecene ROS

  2026-08-07

  This preprint identifies a mechanistic link between caspase-3 activation, cleavage of the mitochondrial complex I subunit NDUFS1, and ROS accumulation after DON or T-2 toxin exposure. It also implicates ER-localized ERO1α as a parallel ROS source, providing a framework for interpreting mitochondrial dysfunction and redox stress in toxin-exposed liver models.

• Novel PDK4 Inhibitors: A New Avenue for Metabolic Disease Th

  2026-08-07

  This study introduces a new class of allosteric PDK4 inhibitors, with compound 8c showing strong in vitro potency and efficacy in animal models of metabolic disease and allergy. These findings highlight the therapeutic promise of targeting PDK4 in conditions like diabetes and allergic inflammation, supported by rigorous pharmacological and mechanistic evaluation.

• Resibufogenin Blocks NLRP3 Inflammasome to Alleviate Atheros

  2026-08-06

  The referenced study demonstrates that resibufogenin (RBG) protects against atherosclerosis in ApoE-/- mice by directly inhibiting NLRP3 inflammasome assembly through specific molecular interactions. This work highlights RBG's dual anti-inflammatory and plaque-stabilizing effects, suggesting its potential as a novel therapeutic approach for cardiovascular disease.

• WNT5a/GSK3/β-catenin Axis Governs FAP Adipogenesis in Muscle

  2026-08-06

  This study identifies the WNT5a/GSK3/β-catenin signaling axis as a pivotal regulator of adipogenic differentiation in skeletal muscle fibro/adipogenic progenitors (FAPs). By integrating pharmacological inhibition, high-dimensional cytometry, and transcriptomics, the authors reveal how modulating this pathway can limit intramuscular fat infiltration—a key concern in myopathy research.

8079 records 3/539 page Previous Next 12345 下5页 Last page